Histomorphometric features of bone in patients with primary and secondary hypoparathyroidism

Kidney International

Volumn 63, Issue 5, 2003, Pages 1809-1816

  Ubara, Yoshifumi ^a   Fushimi, Tomohisa ^a   Tagami, Tetsuo ^a   Sawa, Naoki ^a   Hoshino, Junichi ^a   Yokota, Masafumi ^a   Katori, Hideyuki ^a   Takemoto, Fumi ^a   Hara, Shigeko ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

A long standing low PTH state; Idiopathic adynamic bone disease (ABD); Minimodeling; Primary hypoparathyroidism; Remodeling; Secondary hypoparathyroidism

Indexed keywords

TETRACYCLINE;

ADULT; AGED; ARTICLE; AUTOPSY; BONE MINERAL; BONE REMODELING; CANCELLOUS BONE; CASE REPORT; FEMALE; HEMODIALYSIS; HUMAN; HYPOPARATHYROIDISM; MALE; MORPHOMETRICS; OSSIFICATION; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; TRABECULAR BONE;

EID: 0037407251     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00916.x     Document Type: Article

References (25)

1. ATSUMI K, KUSHIDA K, YANAZAKI K, et al: Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287-293, 1999
2. COCO M, RUSH H: Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115-1121, 2000
3. PIRANO B, CHEN T, COOPERSTEIN L, et al: Fracture and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30:57-62, 1988.
4. HERCZ G, PEI Y, GREENWOOD C, et al: Aplastic osteodydtrophy without aluminum: The role of "suppressed" parathyroid function. Kidney Int 44:860-866, 1993
5. NIKURA K, AKIZAWA T, SATOH Y, et al: Relative hypoparathyroidism in hemodialysis patients. Miner Electrolyte Metab 21:101-103, 1995
6. ABDERHADI M, NORDENSTROM J: Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 83:3845-3851, 1998
7. SHERRARD DJ, BAYLINK DJ, WERGEDAL JE, et al: Quantitative histological studies on the pathogenesis of uremic bone disease. J Clin Endo Metab 39:119-135, 1974
8. SHERRARD DJ, OTT SM, MALONEY NA, et al: Uremic osteodystrophy: Classification, cause, and treatment, in Clinical Disorders of Bone and Mineral Metabolism, edited by FRAME B, POTTS JT JR., Amsterdam, Excerpta Media, 1983, pp 254-259
9. SHERRARD DI, HERCZ G, PEI Y, et al: The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int 43:436-442, 1993
10. COUTTENYE MM, D'HAESE PC, BROE ME: What considerations should we give to adynamic bone disease. J Artificial 21:687-692, 1998
11. UBARA Y: Bone histomorphometrical analysis in patients on long-term dialysis treatment for more than 10 years. Osaka City Med J 44:133-13, 1998
12. FITZPATRICK LA, ARNPLD A: Hypoparathyroidism, in Endocrinology (3rd ed.), edited by DEGROOT LJ, Philadelphia, W.B. Saunders, 1995
13. HRUSKA KA, TEITELBAUM SL: Renal osteodystrophy. N Eng J Med 333:166-174, 1995
14. FROST HM: Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's Law: The bone modeling problem. Anat Rec 226:403-413, 1990
15. FROST HM: Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's Law: The remodeling problem. Anat Rec 226:414-422, 1990
16. FROST HM: Skeletal structural adaptations to mechanical usage (SATMU): 3. The hyaline cartilage modeling problem. Anat Rec 226:423-432, 1990
17. FROST HM: Skeletal structural adaptations to mechanical usage (SATMU): 4. Mechanical influences on intact fibrous tissues. Anat Rec 226:433-439, 1990
18. MALLUCHE HH, MONIER-FAUGERE MC: Understanding and managing hyperphosphatemia in patients with chronic renal disease. Clin Nephrol 52:267-277, 1999
19. BROSSARO JH, CLOUTIER M, ROY L, et al: Accumulation of a non-(1-84) molecular form of parathyroid hormone(PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 81:3923-3929, 1996
20. LEPAGE R, ROY L, BROSSARO JH, et al: A non-(1-84) corculating parathyroid hormone(PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-809, 1998
21. JOHN MR, GOODMAN WG, GAO P, et al: A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290, 1999
22. SLATOPOLSKY E, FINCH J, CLAY P, et al: A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753-761, 2000
23. GAO P, SCHEIBEL S, D'AMOUR P, et al: Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614, 2001
24. MONIER-FAUGERE MC, GENG Z, MAWAD H, et al: improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragment ratio in ESRD patients. Kidney Int 60:1460-1468, 2001
25. COEN G, BONUCCI E, BALLANTI P, et al: PTH "1-84" and PTH 7-84 in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:348-354, 2002